C140H205N11O11S — CID 162177312
N-methyl-N-[3-methyl-3-(4-methylphenyl)butyl]acetamide;2-methyl-N-[3-methyl-3-(4-methylphenyl)butyl]propanamide;N-[3-methyl-3-(4-methylphenyl)butyl]acetamide;3-[3-methyl-3-(4-methylphenyl)butyl]-1H-imidazol-2-one;3-[3-methyl-3-(4-methylphenyl)butyl]-1,3-oxazol-2-one;4-[3-methyl-3-(4-methylphenyl)butyl]piperazin-2-one;1-[3-methyl-3-(4-methylphenyl)butyl]piperidin-4-ol;1-[3-methyl-3-(4-methylphenyl)butyl]-2H-pyrrol-5-one;4-[3-methyl-3-(4-methylphenyl)butyl]-1,4-thiazinane 1,1-dioxide (PubChem CID 162177312) has the molecular formula C140H205N11O11S and a molecular weight of 2250.31 g/mol. Its IUPAC name is N-methyl-N-[3-methyl-3-(4-methylphenyl)butyl]acetamide;2-methyl-N-[3-methyl-3-(4-methylphenyl)butyl]propanamide;N-[3-methyl-3-(4-methylphenyl)butyl]acetamide;3-[3-methyl-3-(4-methylphenyl)butyl]-1H-imidazol-2-one;3-[3-methyl-3-(4-methylphenyl)butyl]-1,3-oxazol-2-one;4-[3-methyl-3-(4-methylphenyl)butyl]piperazin-2-one;1-[3-methyl-3-(4-methylphenyl)butyl]piperidin-4-ol;1-[3-methyl-3-(4-methylphenyl)butyl]-2H-pyrrol-5-one;4-[3-methyl-3-(4-methylphenyl)butyl]-1,4-thiazinane 1,1-dioxide.
| Compound Name | N-methyl-N-[3-methyl-3-(4-methylphenyl)butyl]acetamide;2-methyl-N-[3-methyl-3-(4-methylphenyl)butyl]propanamide;N-[3-methyl-3-(4-methylphenyl)butyl]acetamide;3-[3-methyl-3-(4-methylphenyl)butyl]-1H-imidazol-2-one;3-[3-methyl-3-(4-methylphenyl)butyl]-1,3-oxazol-2-one;4-[3-methyl-3-(4-methylphenyl)butyl]piperazin-2-one;1-[3-methyl-3-(4-methylphenyl)butyl]piperidin-4-ol;1-[3-methyl-3-(4-methylphenyl)butyl]-2H-pyrrol-5-one;4-[3-methyl-3-(4-methylphenyl)butyl]-1,4-thiazinane 1,1-dioxide |
|---|---|
| PubChem CID | 162177312 |
| Molecular Formula | C140H205N11O11S |
| Molecular Weight | 2250.31 g/mol |
| Exact Mass | 2248.55 |
| IUPAC Name | N-methyl-N-[3-methyl-3-(4-methylphenyl)butyl]acetamide;2-methyl-N-[3-methyl-3-(4-methylphenyl)butyl]propanamide;N-[3-methyl-3-(4-methylphenyl)butyl]acetamide;3-[3-methyl-3-(4-methylphenyl)butyl]-1H-imidazol-2-one;3-[3-methyl-3-(4-methylphenyl)butyl]-1,3-oxazol-2-one;4-[3-methyl-3-(4-methylphenyl)butyl]piperazin-2-one;1-[3-methyl-3-(4-methylphenyl)butyl]piperidin-4-ol;1-[3-methyl-3-(4-methylphenyl)butyl]-2H-pyrrol-5-one;4-[3-methyl-3-(4-methylphenyl)butyl]-1,4-thiazinane 1,1-dioxide |
| SMILES | CC(=O)N(C)CCC(C)(C)c1ccc(C)cc1.CC(=O)NCCC(C)(C)c1ccc(C)cc1.Cc1ccc(C(C)(C)CCN2CC=CC2=O)cc1.Cc1ccc(C(C)(C)CCN2CCC(O)CC2)cc1.Cc1ccc(C(C)(C)CCN2CCNC(=O)C2)cc1.Cc1ccc(C(C)(C)CCN2CCS(=O)(=O)CC2)cc1.Cc1ccc(C(C)(C)CCNC(=O)C(C)C)cc1.Cc1ccc(C(C)(C)CCn2cc[nH]c2=O)cc1.Cc1ccc(C(C)(C)CCn2ccoc2=O)cc1 |
| InChI | InChI=1S/C17H27NO.C16H24N2O.C16H25NO2S.C16H21NO.C16H25NO.C15H20N2O.C15H19NO2.C15H23NO.C14H21NO/c1-14-4-6-15(7-5-14)17(2,3)10-13-18-11-8-16(19)9-12-18;1-13-4-6-14(7-5-13)16(2,3)8-10-18-11-9-17-15(19)12-18;1-14-4-6-15(7-5-14)16(2,3)8-9-17-10-12-20(18,19)13-11-17;1-13-6-8-14(9-7-13)16(2,3)10-12-17-11-4-5-15(17)18;1-12(2)15(18)17-11-10-16(4,5)14-8-6-13(3)7-9-14;1-12-4-6-13(7-5-12)15(2,3)8-10-17-11-9-16-14(17)18;1-12-4-6-13(7-5-12)15(2,3)8-9-16-10-11-18-14(16)17;1-12-6-8-14(9-7-12)15(3,4)10-11-16(5)13(2)17;1-11-5-7-13(8-6-11)14(3,4)9-10-15-12(2)16/h4-7,16,19H,8-13H2,1-3H3;4-7H,8-12H2,1-3H3,(H,17,19);4-7H,8-13H2,1-3H3;4-9H,10-12H2,1-3H3;6-9,12H,10-11H2,1-5H3,(H,17,18);4-7,9,11H,8,10H2,1-3H3,(H,16,18);4-7,10-11H,8-9H2,1-3H3;6-9H,10-11H2,1-5H3;5-8H,9-10H2,1-4H3,(H,15,16) |
| InChIKey | ZOOAWXQFXVYIIX-UHFFFAOYSA-N |
| XLogP | 26.01 |
| TPSA | 264.94 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 37 |
| Heavy Atoms | 163 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2250.31 |
| LogP ≤ 5 | 26.01 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 16 |